4
Kenya has begun a phased rollout of a new HIV prevention pill following regulatory approval, marking a major step in efforts to curb new infections. The long‑acting medication will first be distributed to high‑risk populations before nationwide expansion. Scientists say uptake of new prevention options is crucial as infection rates plateau among young adults. Awareness campaigns and training for health providers are expected to accompany the rollout.